Meridian Investment Counsel Inc. Acquires 5,312 Shares of SPDR S&P Biotech ETF $XBI

Meridian Investment Counsel Inc. grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 37.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 19,578 shares of the exchange traded fund’s stock after acquiring an additional 5,312 shares during the period. Meridian Investment Counsel Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,501,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Avoro Capital Advisors LLC purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $256,053,000. Wells Fargo & Company MN increased its holdings in shares of SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after acquiring an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp increased its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after acquiring an additional 1,187,907 shares in the last quarter. Morgan Stanley raised its position in shares of SPDR S&P Biotech ETF by 8.3% in the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. raised its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after purchasing an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $160.46 on Monday. The stock has a market cap of $10.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. The firm’s 50-day moving average is $137.41 and its 200 day moving average is $130.02. SPDR S&P Biotech ETF has a 1 year low of $83.02 and a 1 year high of $160.82.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.